Beyond conventional antibiotics - New directions for combination products to combat biofilm

被引:56
作者
Bayramov, Danir Fanisovich [1 ]
Neff, Jennifer Ann [1 ]
机构
[1] Allvivo Vasc Inc, 20914 Bake Pkwy,Suite 100, Lake Forest, CA 92630 USA
基金
美国国家卫生研究院;
关键词
Antimicrobial; Antimicrobial peptides; Antibiotic resistance; Compartment model; Local drug delivery; Medical device coatings; CATIONIC ANTIMICROBIAL PEPTIDES; CENTRAL VENOUS CATHETERS; HOST-DEFENSE PEPTIDES; BLOOD-STREAM INFECTIONS; PSEUDOMONAS-AERUGINOSA; IN-VITRO; STAPHYLOCOCCUS-AUREUS; MICROBIAL BIOFILMS; RESISTANCE MECHANISMS; GENTAMICIN-RELEASE;
D O I
10.1016/j.addr.2016.07.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Medical device related infections are a significant and growing source of morbidity and mortality. Biofilm formation is a common feature of medical device infections that is not effectively prevented or treated by systemic antibiotics. Antimicrobialmedical device combination products provide a pathway for local delivery of antimicrobial therapeutics with the ability to achieve high local concentrations while minimizing systemic side effects. In this review, we present considerations for the design of local antimicrobial delivery systems, which can be facilitated by modeling local pharmacokinetics in the context of the target device application. In addition to the need for local delivery, a critical barrier to progress in the field is the need to incorporate agents effective against bio-film. This article aims to review key properties of antimicrobial peptides that make them well suited to meet the demands of the next generation of antimicrobial medical devices, including broad spectrum activity, rapid and biocidal mechanisms of action, and efficacy against biofilm. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 60
页数:13
相关论文
共 194 条
  • [41] Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood:: Implications for systemic applications
    Deslouches, B
    Islam, K
    Craigo, JK
    Paranjape, SM
    Montelaro, RC
    Mietzner, TA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3208 - 3216
  • [42] De nova generation of cationic antimicrobial peptides: Influence of length and tryptophan substitution on antimicrobial activity
    Deslouches, B
    Phadke, SM
    Lazarevic, V
    Cascio, M
    Islam, K
    Montelaro, RC
    Mietzner, TA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) : 316 - 322
  • [43] De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia
    Deslouches, Berthony
    Gonzalez, Ivan A.
    DeAlmeida, Dilhari
    Islam, Kazi
    Steele, Chad
    Montelaro, Ronald C.
    Mietzner, Timothy A.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (03) : 669 - 672
  • [44] Engineered Cationic Antimicrobial Peptides To Overcome Multidrug Resistance by ESKAPE Pathogens
    Deslouches, Berthony
    Steckbeck, Jonathan D.
    Craigo, Jodi K.
    Doi, Yohei
    Burns, Jane L.
    Montelaro, Ronald C.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 1329 - 1333
  • [45] Rational Design of Engineered Cationic Antimicrobial Peptides Consisting Exclusively of Arginine and Tryptophan, and Their Activity against Multidrug-Resistant Pathogens
    Deslouches, Berthony
    Steckbeck, Jonathan D.
    Craigo, Jodi K.
    Doi, Yohei
    Mietzner, Timothy A.
    Montelaro, Ronald C.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) : 2511 - 2521
  • [46] Biofilms: Microbial life on surfaces
    Donlan, RM
    [J]. EMERGING INFECTIOUS DISEASES, 2002, 8 (09) : 881 - 890
  • [47] ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
  • [48] Cationic Amphiphiles, a New Generation of Antimicrobials Inspired by the Natural Antimicrobial Peptide Scaffold
    Findlay, Brandon
    Zhanel, George G.
    Schweizer, Frank
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4049 - 4058
  • [49] Designing antimicrobial peptides: form follows function
    Fjell, Christopher D.
    Hiss, Jan A.
    Hancock, Robert E. W.
    Schneider, Gisbert
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (01) : 37 - 51
  • [50] Antimicrobial peptides stage a comeback
    Fox, Jeffrey L.
    [J]. NATURE BIOTECHNOLOGY, 2013, 31 (05) : 379 - 382